HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc Janier Selected Research

Biomarkers (Surrogate Marker)

3/2012Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc Janier Research Topics

Disease

17Neoplasms (Cancer)
08/2021 - 01/2008
4Brain Neoplasms (Brain Tumor)
03/2014 - 12/2011
3Gliosarcoma
03/2014 - 09/2013
2Prostatic Neoplasms (Prostate Cancer)
01/2021 - 04/2004
2Melanoma (Melanoma, Malignant)
01/2019 - 02/2013
2Squamous Cell Carcinoma of Head and Neck
11/2017 - 01/2015
2Lung Injury
08/2008 - 11/2006
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2021
1Lymphoma (Lymphomas)
01/2018
1Neutropenia
01/2018
1Chondrosarcoma
11/2014
1Myotonic Dystrophy (Dystrophia Myotonica)
03/2012
1Disease Progression
03/2012
1Renal Artery Obstruction (Renal Artery Stenosis)
04/2011
1Glioma (Gliomas)
08/2009
1Uveitis
05/2009
1Brain Ischemia (Cerebral Ischemia)
05/2007
1Ischemic Stroke
05/2007
1Ischemia
05/2007
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2007
1Stroke (Strokes)
05/2007
1Malignant Mesothelioma
06/2006
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
06/2006
1Pathologic Constriction (Stenosis)
12/2003
1Thyroid Neoplasms (Thyroid Cancer)
10/2003
1Long QT Syndrome
09/2003

Drug/Important Bio-Agent (IBA)

5GadoliniumIBA
11/2017 - 12/2011
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2021 - 10/2003
3Radiation-Sensitizing AgentsIBA
01/2019 - 12/2011
2fluorocholineIBA
01/2021 - 01/2008
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2018 - 01/2018
2GoldIBA
03/2014 - 02/2014
2Oleic Acid (Oleate)IBA
08/2008 - 11/2006
1Chimeric Antigen ReceptorsIBA
08/2021
1gallium 68 PSMA-11IBA
01/2021
1Monoclonal AntibodiesIBA
01/2018
1Rituximab (Mabthera)FDA Link
01/2018
1Pentetic Acid (DTPA)FDA LinkGeneric
01/2018
1CarbonIBA
11/2017
1IonsIBA
11/2017
1OligonucleotidesIBA
01/2016
1Dendrimers (Dendrons)IBA
03/2015
1Siloxanes (Siloxane)IBA
11/2014
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2014
1Ammonium CompoundsIBA
11/2014
1IndiumIBA
11/2014
1Proteoglycans (Proteoglycan)IBA
04/2013
1Melanins (Melanin)IBA
02/2013
1Biomarkers (Surrogate Marker)IBA
03/2012
1Oxygen (Dioxygen)IBA
04/2011
1Choline (Choline Chloride)IBA
08/2009
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
08/2009
1Fluorine-18IBA
05/2009
1PPAR alphaIBA
05/2007
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2007
1PPAR-betaIBA
05/2007
1gadodiamide (Omniscan)FDA Link
12/2003
1ThalliumIBA
12/2003
1IodineIBA
10/2003
1SodiumIBA
09/2003
1Potassium Channels (Potassium Channel)IBA
09/2003

Therapy/Procedure

6Intravenous Injections
03/2015 - 04/2013
4Radiotherapy
01/2015 - 04/2004
2Therapeutics
07/2013 - 04/2013
1Immunotherapy
01/2018
1Precision Medicine
09/2013
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
08/2008
1Salvage Therapy
04/2004